![](https://images.squarespace-cdn.com/content/v1/636934fdbb8bde6edeb455cd/5fdbc780-5a63-48ab-9fd3-ccdf6f4b608e/Verpora-Knowledge-bg.jpg)
Knowledge & Resources
Expert insights and knowledge on global Innovative Contracting, VBA,
Market Access and Human Performance Factors
Innovative Contracting & VBA
Articles & Whitepapers
![Is VBP the new VBC for U.S. Drug Prices?](https://images.squarespace-cdn.com/content/v1/636934fdbb8bde6edeb455cd/0e770666-daf7-4875-be99-beaa8bfe1b58/vbp-whitepaper-thumbnail.png)
Is VBP the new VBC for U.S. Drug Prices?
All U.S. healthcare stakeholders recognize that the overheated drugs market is not sustainable. The ever-growing spiral of rising gross prices, often accompanied by increasing rebates and returns, is not a model fit for purpose now, let alone the future.
![Value-based Agreements deliver U.S. Patient and Caregiver Benefits: New Evidence](https://images.squarespace-cdn.com/content/v1/636934fdbb8bde6edeb455cd/0e770666-daf7-4875-be99-beaa8bfe1b58/vbp-whitepaper-thumbnail.png)
Value-based Agreements deliver U.S. Patient and Caregiver Benefits: New Evidence
National and regional payers identify the real-world advantages of innovative contracts